Standout Papers

Avidity in antibody effector functions and biotherapeutic drug design 2022 2026 2023 2024121
  1. Avidity in antibody effector functions and biotherapeutic drug design (2022)
    Simone C. Oostindie, Greg A. Lazar et al. Nature Reviews Drug Discovery

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
3 intermediate papers

Works of Simone C. Oostindie being referenced

DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies
2020
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Simone C. Oostindie 342 260 201 14 557
Bernd Hubner 211 254 275 15 577
Christian K. Behrens 187 296 235 13 544
Klaus Koefoed 295 131 243 17 588
A J Infante 225 314 176 21 625
Koen Wagner 184 182 216 21 611
Hok Seon Kim 218 203 205 11 476
Björn Cochlovius 339 259 304 17 536
Paul R. Hinton 444 203 356 20 576
Dalal Aldeghaither 166 197 177 12 627
Ling C. Santora 389 181 362 10 566

All Works

Loading papers...

Rankless by CCL
2026